# Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

> **NCT01363843** · PHASE2 · COMPLETED · sponsor: **William Sikov MD** · enrollment: 39 (actual)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** FOLFOX6
- **RADIATION:** RT with concurrent chemotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01363843
- **Lead sponsor:** William Sikov MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363843, "Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01363843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*